Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface

E-ISSN： 2212-389x|2|2|157-163

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.2, Iss.2, 2007-01, pp. : 157-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapies directed at vascular endothelial growth factor

By Manley Paul W Martiny-Baron Georg Schlaeppi Jean-Marc Wood Jeanette M

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1715-1736

Informa Healthcare

Access to resources Recommend Favorite

Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 603-612

Bentham Science Publishers

Access to resources Recommend Favorite

SIRT3: Oncogene and Tumor Suppressor in Cancer

By Torrens-Mas Margalida Oliver Jordi Roca Pilar Sastre-Serra Jorge

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 90-90

MDPI

Access to resources Recommend Favorite

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 39-44

Spandidos Publications

Access to resources Recommend Favorite

Expression of p53 and Vascular Endothelial Growth Factor Associated with Tumor Angiogenesis and Prognosis in Gastric Cancer

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 594-599

Karger

Access to resources Recommend Favorite